Temple Pathology Grand Rounds Seminar & Webinar Friday 12/2/16
“Many “Reactive Lesions” of Bone are Probably Neoplasms”
Gene P. Siegal, M.D., Ph.D.
Robert W. Mowry Endowed Professor of Pathology
Professor of Surgery and Cell, Developmental and Integrative Biology
Department of Pathology
The University of Alabama at Birmingham
Editor-in-Chief Laboratory Investigation
To attend in person: 12:00PM – 1:00PM ET
Friday, December 2, 2016
Medical Education Research Building,
8th Floor, Room 810
Please bring your lunch
To attend remotely by webinar:
1. You can remotely attend from anywhere in the world by any computer with speakers & Internet.
2. Go to: join the meeting https://templeuniversity.webex.com/templeuniversity/j.php?MTID=mc089c891a3d3da0a7de33eb8fc327699
3. Meeting Number: 646 643 624
4. Click "Join". You will need to have either: Flash Player 6.0, Windows Media Player 9.0, QuickTime 7.1 or later versions of these.
5. For Webinar CME credits contact email@example.com, free to TUHS staff, $10 for others.
At the conclusion of this conference, the participant should be able to:
1. What are the demographic, radiologic and histologic determinates of “reactive lesions” of bone?
2. What are the molecular changes associated with “reactive lesions” of bone?
3. What are the typical and unusual sites of origin of “reactive lesions” of bone?
Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for Physicians.
Temple University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
It is the policy of Temple University School of Medicine, The Albert J. Finestone, M.D. Office for Continuing Medical Education to insure balance, independence, objectivity and scientific rigor in all of its sponsored or jointly sponsored educational programs. All faculty participating in programs sponsored or jointly sponsored by Temple University School of Medicine are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Temple University School of Medicine, Temple University Health System or its affiliates. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.